{
  "episodes": [
    {
      "index": 1,
      "date": "2024-03-04",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 45,
        "active": 45,
        "screen_failures_cumulative": 1,
        "withdrawals_cumulative": 0,
        "by_dose_group": {
          "low_dose": 12,
          "mid_dose": 10,
          "high_dose": 12,
          "placebo": 11
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 20.2,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 14.0,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 40.3,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 64.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 38.0,
            "sd": 11.0
          },
          "seroconversion_pct": 9.0
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 38.6,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 20.5,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 70.7,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 104.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 73.0,
            "sd": 18.0
          },
          "seroconversion_pct": 16.0
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 51.7,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 30.0,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 91.9,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 134.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 89.0,
            "sd": 24.0
          },
          "seroconversion_pct": 26.9
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 1.8,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 3.8,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 4.0,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 5.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 3.0,
            "sd": 2.0
          },
          "seroconversion_pct": 1.9
        }
      },
      "injection_site_reactions": {
        "pain_pct": 62.5,
        "erythema_pct": 23.4,
        "swelling_pct": 8.3,
        "induration_pct": 9.7,
        "mean_pain_duration_hours": 46.1
      },
      "systemic_reactogenicity": {
        "fever_pct": 16.8,
        "fatigue_pct": 20.1,
        "myalgia_pct": 20.3,
        "headache_pct": 16.0,
        "chills_pct": 6.3
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 7.5,
          "sd": 1.2
        },
        "lymphocyte_pct": {
          "mean": 30.5,
          "sd": 7.3
        },
        "neutrophil_pct": {
          "mean": 53.9,
          "sd": 9.7
        },
        "platelets_k": {
          "mean": 222,
          "sd": 43
        },
        "crp_mg_l": {
          "mean": 6.4,
          "sd": 1.5
        },
        "hemoglobin_g_dl": {
          "mean": 14.1,
          "sd": 0.9
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-0187",
          "description": "arthralgia",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-0156",
          "description": "malaise",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        }
      ],
      "events": [
        "Site 05 monitoring visit, 2 minor findings",
        "Cold chain temperature log reviewed: all within -70C +/- 5C",
        "Serum sample aliquoting completed for 14 subjects"
      ],
      "notes": "Week 1: Immunogenicity assessments on schedule. 45 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 2,
      "date": "2024-03-11",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 55,
        "active": 55,
        "screen_failures_cumulative": 3,
        "withdrawals_cumulative": 0,
        "by_dose_group": {
          "low_dose": 14,
          "mid_dose": 14,
          "high_dose": 13,
          "placebo": 14
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 24.1,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 14.3,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 32.3,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 65.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 42.0,
            "sd": 11.0
          },
          "seroconversion_pct": 5.8
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 40.1,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 17.6,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 67.5,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 94.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 74.0,
            "sd": 18.0
          },
          "seroconversion_pct": 11.3
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 50.5,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 24.9,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 82.0,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 125.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 95.0,
            "sd": 24.0
          },
          "seroconversion_pct": 19.9
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 6.7,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 0.2,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 1.3,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 5.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 2.0,
            "sd": 2.0
          },
          "seroconversion_pct": 0
        }
      },
      "injection_site_reactions": {
        "pain_pct": 44.4,
        "erythema_pct": 12.8,
        "swelling_pct": 6.8,
        "induration_pct": 10.9,
        "mean_pain_duration_hours": 12.5
      },
      "systemic_reactogenicity": {
        "fever_pct": 13.9,
        "fatigue_pct": 43.5,
        "myalgia_pct": 24.5,
        "headache_pct": 29.3,
        "chills_pct": 7.2
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 7.6,
          "sd": 2.0
        },
        "lymphocyte_pct": {
          "mean": 37.7,
          "sd": 5.2
        },
        "neutrophil_pct": {
          "mean": 61.7,
          "sd": 9.6
        },
        "platelets_k": {
          "mean": 250,
          "sd": 42
        },
        "crp_mg_l": {
          "mean": 5.0,
          "sd": 1.2
        },
        "hemoglobin_g_dl": {
          "mean": 13.1,
          "sd": 0.8
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-0287",
          "description": "lymphadenopathy",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-0212",
          "description": "chills",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-0254",
          "description": "injection site pain",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-0286",
          "description": "lymphadenopathy",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        }
      ],
      "events": [
        "Site 03 monitoring visit, 1 minor findings",
        "T-cell assay batch B02 processed, results QC'd"
      ],
      "notes": "Week 2: Immunogenicity assessments on schedule. 55 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 3,
      "date": "2024-03-18",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 67,
        "active": 67,
        "screen_failures_cumulative": 5,
        "withdrawals_cumulative": 0,
        "by_dose_group": {
          "low_dose": 18,
          "mid_dose": 17,
          "high_dose": 16,
          "placebo": 16
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 24.8,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 14.9,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 38.8,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 65.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 45.0,
            "sd": 11.0
          },
          "seroconversion_pct": 11.9
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 48.1,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 24.3,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 72.3,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 106.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 77.0,
            "sd": 18.0
          },
          "seroconversion_pct": 14.5
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 63.5,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 30.5,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 95.5,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 152.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 108.0,
            "sd": 24.0
          },
          "seroconversion_pct": 29.4
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 10.7,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 2.9,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 4.6,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 5.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 7.0,
            "sd": 2.0
          },
          "seroconversion_pct": 6.9
        }
      },
      "injection_site_reactions": {
        "pain_pct": 51.7,
        "erythema_pct": 14.6,
        "swelling_pct": 7.8,
        "induration_pct": 10.0,
        "mean_pain_duration_hours": 25.5
      },
      "systemic_reactogenicity": {
        "fever_pct": 18.2,
        "fatigue_pct": 32.7,
        "myalgia_pct": 25.9,
        "headache_pct": 17.3,
        "chills_pct": 14.8
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 8.9,
          "sd": 1.9
        },
        "lymphocyte_pct": {
          "mean": 28.7,
          "sd": 6.8
        },
        "neutrophil_pct": {
          "mean": 62.2,
          "sd": 6.2
        },
        "platelets_k": {
          "mean": 216,
          "sd": 39
        },
        "crp_mg_l": {
          "mean": 6.3,
          "sd": 1.9
        },
        "hemoglobin_g_dl": {
          "mean": 13.8,
          "sd": 1.3
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-0303",
          "description": "lymphadenopathy",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-0346",
          "description": "fever",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-0386",
          "description": "injection site pain",
          "grade": 2,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "low_dose"
        }
      ],
      "events": [
        "Serum sample aliquoting completed for 25 subjects",
        "Serum sample aliquoting completed for 19 subjects"
      ],
      "notes": "Week 3: Immunogenicity assessments on schedule. 67 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 4,
      "date": "2024-03-25",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 80,
        "active": 80,
        "screen_failures_cumulative": 6,
        "withdrawals_cumulative": 0,
        "by_dose_group": {
          "low_dose": 20,
          "mid_dose": 21,
          "high_dose": 20,
          "placebo": 19
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 32.6,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 16.9,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 46.4,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 85.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 54.0,
            "sd": 11.0
          },
          "seroconversion_pct": 12.1
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 52.1,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 25.3,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 80.7,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 120.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 90.0,
            "sd": 18.0
          },
          "seroconversion_pct": 19.6
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 71.3,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 33.2,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 122.2,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 178.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 121.0,
            "sd": 24.0
          },
          "seroconversion_pct": 25.2
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 11.3,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 0.7,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 8.0,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 25.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 10.0,
            "sd": 2.0
          },
          "seroconversion_pct": 0.9
        }
      },
      "injection_site_reactions": {
        "pain_pct": 53.7,
        "erythema_pct": 12.6,
        "swelling_pct": 17.6,
        "induration_pct": 4.4,
        "mean_pain_duration_hours": 18.8
      },
      "systemic_reactogenicity": {
        "fever_pct": 19.9,
        "fatigue_pct": 38.1,
        "myalgia_pct": 30.2,
        "headache_pct": 27.5,
        "chills_pct": 10.1
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 7.1,
          "sd": 1.3
        },
        "lymphocyte_pct": {
          "mean": 32.0,
          "sd": 5.2
        },
        "neutrophil_pct": {
          "mean": 63.7,
          "sd": 5.4
        },
        "platelets_k": {
          "mean": 218,
          "sd": 41
        },
        "crp_mg_l": {
          "mean": 7.7,
          "sd": 1.9
        },
        "hemoglobin_g_dl": {
          "mean": 14.2,
          "sd": 1.2
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-0417",
          "description": "lymphadenopathy",
          "grade": 2,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-0429",
          "description": "nausea",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-0425",
          "description": "malaise",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        }
      ],
      "events": [
        "Vaccination day 1: 21 subjects received scheduled dose",
        "Immunology core lab QC report received"
      ],
      "notes": "Week 4: Immunogenicity assessments on schedule. 80 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 5,
      "date": "2024-04-01",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 92,
        "active": 90,
        "screen_failures_cumulative": 9,
        "withdrawals_cumulative": 2,
        "by_dose_group": {
          "low_dose": 21,
          "mid_dose": 25,
          "high_dose": 24,
          "placebo": 22
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 40.4,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 16.0,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 54.7,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 97.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 65.0,
            "sd": 11.0
          },
          "seroconversion_pct": 17.1
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 57.4,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 30.2,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 98.3,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 140.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 98.0,
            "sd": 18.0
          },
          "seroconversion_pct": 19.4
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 75.4,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 37.1,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 129.5,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 201.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 129.0,
            "sd": 24.0
          },
          "seroconversion_pct": 34.8
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 4.9,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 5.6,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 5.0,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 8.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 16.0,
            "sd": 2.0
          },
          "seroconversion_pct": 5.4
        }
      },
      "injection_site_reactions": {
        "pain_pct": 52.9,
        "erythema_pct": 26.9,
        "swelling_pct": 7.8,
        "induration_pct": 9.4,
        "mean_pain_duration_hours": 23.0
      },
      "systemic_reactogenicity": {
        "fever_pct": 21.4,
        "fatigue_pct": 33.9,
        "myalgia_pct": 34.2,
        "headache_pct": 16.1,
        "chills_pct": 14.3
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 8.8,
          "sd": 1.4
        },
        "lymphocyte_pct": {
          "mean": 28.8,
          "sd": 7.7
        },
        "neutrophil_pct": {
          "mean": 58.6,
          "sd": 6.5
        },
        "platelets_k": {
          "mean": 244,
          "sd": 38
        },
        "crp_mg_l": {
          "mean": 1.6,
          "sd": 1.7
        },
        "hemoglobin_g_dl": {
          "mean": 13.4,
          "sd": 0.8
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-0507",
          "description": "myalgia",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-0573",
          "description": "lymphadenopathy",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-0595",
          "description": "lymphadenopathy",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-0591",
          "description": "injection site pain",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        }
      ],
      "events": [
        "Serology samples shipped to central immunology lab",
        "Vaccination day 6: 17 subjects received scheduled dose"
      ],
      "notes": "Week 5: Immunogenicity assessments on schedule. 92 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 6,
      "date": "2024-04-08",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 106,
        "active": 105,
        "screen_failures_cumulative": 10,
        "withdrawals_cumulative": 1,
        "by_dose_group": {
          "low_dose": 27,
          "mid_dose": 26,
          "high_dose": 28,
          "placebo": 25
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 35.4,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 20.3,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 71.9,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 92.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 62.0,
            "sd": 11.0
          },
          "seroconversion_pct": 17.9
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 64.4,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 32.2,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 104.8,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 156.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 105.0,
            "sd": 18.0
          },
          "seroconversion_pct": 26.5
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 93.0,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 41.0,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 141.8,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 212.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 151.0,
            "sd": 24.0
          },
          "seroconversion_pct": 31.8
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 11.3,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 4.9,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 16.7,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 12.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 19.0,
            "sd": 2.0
          },
          "seroconversion_pct": 3.6
        }
      },
      "injection_site_reactions": {
        "pain_pct": 61.8,
        "erythema_pct": 13.9,
        "swelling_pct": 16.7,
        "induration_pct": 6.4,
        "mean_pain_duration_hours": 19.6
      },
      "systemic_reactogenicity": {
        "fever_pct": 21.2,
        "fatigue_pct": 42.9,
        "myalgia_pct": 31.4,
        "headache_pct": 18.9,
        "chills_pct": 5.7
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 5.5,
          "sd": 1.7
        },
        "lymphocyte_pct": {
          "mean": 37.5,
          "sd": 4.7
        },
        "neutrophil_pct": {
          "mean": 57.9,
          "sd": 7.9
        },
        "platelets_k": {
          "mean": 220,
          "sd": 40
        },
        "crp_mg_l": {
          "mean": 7.5,
          "sd": 0.6
        },
        "hemoglobin_g_dl": {
          "mean": 13.7,
          "sd": 1.3
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-0627",
          "description": "fatigue",
          "grade": 1,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-0632",
          "description": "lymphadenopathy",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-0610",
          "description": "arthralgia",
          "grade": 2,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "low_dose"
        }
      ],
      "events": [
        "Serology samples shipped to central immunology lab",
        "DSMB safety review teleconference completed",
        "Serum sample aliquoting completed for 15 subjects"
      ],
      "notes": "Week 6: Immunogenicity assessments on schedule. 106 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 7,
      "date": "2024-04-15",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 105,
        "active": 103,
        "screen_failures_cumulative": 12,
        "withdrawals_cumulative": 2,
        "by_dose_group": {
          "low_dose": 25,
          "mid_dose": 25,
          "high_dose": 27,
          "placebo": 28
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 48.5,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 16.4,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 62.3,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 109.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 68.0,
            "sd": 11.0
          },
          "seroconversion_pct": 21.1
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 73.5,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 29.0,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 115.2,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 165.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 125.0,
            "sd": 18.0
          },
          "seroconversion_pct": 28.7
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 100.6,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 42.0,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 147.4,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 235.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 162.0,
            "sd": 24.0
          },
          "seroconversion_pct": 41.4
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 6.8,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 5.1,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 14.0,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 25.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 16.0,
            "sd": 2.0
          },
          "seroconversion_pct": 5.5
        }
      },
      "injection_site_reactions": {
        "pain_pct": 50.9,
        "erythema_pct": 28.9,
        "swelling_pct": 9.9,
        "induration_pct": 8.8,
        "mean_pain_duration_hours": 34.2
      },
      "systemic_reactogenicity": {
        "fever_pct": 16.6,
        "fatigue_pct": 23.1,
        "myalgia_pct": 27.9,
        "headache_pct": 19.5,
        "chills_pct": 14.4
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 9.0,
          "sd": 1.5
        },
        "lymphocyte_pct": {
          "mean": 39.9,
          "sd": 7.8
        },
        "neutrophil_pct": {
          "mean": 56.0,
          "sd": 6.5
        },
        "platelets_k": {
          "mean": 237,
          "sd": 43
        },
        "crp_mg_l": {
          "mean": 5.5,
          "sd": 1.6
        },
        "hemoglobin_g_dl": {
          "mean": 13.9,
          "sd": 0.8
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-0771",
          "description": "malaise",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-0765",
          "description": "injection site pain",
          "grade": 1,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-0749",
          "description": "headache",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-0701",
          "description": "fatigue",
          "grade": 1,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "low_dose"
        }
      ],
      "events": [
        "Serum sample aliquoting completed for 20 subjects",
        "Cold chain temperature log reviewed: all within -70C +/- 5C"
      ],
      "notes": "Week 7: Immunogenicity assessments on schedule. 105 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 8,
      "date": "2024-04-22",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 107,
        "active": 105,
        "screen_failures_cumulative": 12,
        "withdrawals_cumulative": 2,
        "by_dose_group": {
          "low_dose": 25,
          "mid_dose": 27,
          "high_dose": 26,
          "placebo": 29
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 45.6,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 17.8,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 74.3,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 121.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 82.0,
            "sd": 11.0
          },
          "seroconversion_pct": 16.1
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 83.3,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 33.0,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 120.8,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 191.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 130.0,
            "sd": 18.0
          },
          "seroconversion_pct": 36.0
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 106.0,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 40.8,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 176.1,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 257.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 180.0,
            "sd": 24.0
          },
          "seroconversion_pct": 45.0
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 5.9,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 3.4,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 10.9,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 21.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 17.0,
            "sd": 2.0
          },
          "seroconversion_pct": 7.7
        }
      },
      "injection_site_reactions": {
        "pain_pct": 47.4,
        "erythema_pct": 19.4,
        "swelling_pct": 14.5,
        "induration_pct": 8.8,
        "mean_pain_duration_hours": 17.7
      },
      "systemic_reactogenicity": {
        "fever_pct": 15.2,
        "fatigue_pct": 31.9,
        "myalgia_pct": 19.0,
        "headache_pct": 26.4,
        "chills_pct": 5.3
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 7.2,
          "sd": 1.8
        },
        "lymphocyte_pct": {
          "mean": 26.0,
          "sd": 5.8
        },
        "neutrophil_pct": {
          "mean": 52.9,
          "sd": 6.9
        },
        "platelets_k": {
          "mean": 219,
          "sd": 39
        },
        "crp_mg_l": {
          "mean": 2.0,
          "sd": 1.2
        },
        "hemoglobin_g_dl": {
          "mean": 14.6,
          "sd": 1.4
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-0818",
          "description": "lymphadenopathy",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-0817",
          "description": "malaise",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        }
      ],
      "events": [
        "Reactogenicity diary card collection rate: 95%",
        "Vaccine lot VX-645 temperature excursion assessed: within acceptable range"
      ],
      "notes": "Week 8: Immunogenicity assessments on schedule. 107 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 9,
      "date": "2024-04-29",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 106,
        "active": 104,
        "screen_failures_cumulative": 12,
        "withdrawals_cumulative": 2,
        "by_dose_group": {
          "low_dose": 25,
          "mid_dose": 25,
          "high_dose": 28,
          "placebo": 28
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 56.0,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 19.1,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 94.3,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 136.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 97.0,
            "sd": 11.0
          },
          "seroconversion_pct": 25.1
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 94.6,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 29.4,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 147.2,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 212.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 161.0,
            "sd": 18.0
          },
          "seroconversion_pct": 32.4
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 121.7,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 38.8,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 200.1,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 300.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 216.0,
            "sd": 24.0
          },
          "seroconversion_pct": 51.1
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 6.5,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 3.5,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 17.2,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 25.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 25.0,
            "sd": 2.0
          },
          "seroconversion_pct": 4.5
        }
      },
      "injection_site_reactions": {
        "pain_pct": 54.3,
        "erythema_pct": 21.9,
        "swelling_pct": 17.9,
        "induration_pct": 7.8,
        "mean_pain_duration_hours": 39.4
      },
      "systemic_reactogenicity": {
        "fever_pct": 12.8,
        "fatigue_pct": 40.6,
        "myalgia_pct": 23.2,
        "headache_pct": 29.7,
        "chills_pct": 8.4
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 6.5,
          "sd": 1.7
        },
        "lymphocyte_pct": {
          "mean": 25.0,
          "sd": 4.1
        },
        "neutrophil_pct": {
          "mean": 46.9,
          "sd": 8.0
        },
        "platelets_k": {
          "mean": 220,
          "sd": 41
        },
        "crp_mg_l": {
          "mean": 5.7,
          "sd": 1.1
        },
        "hemoglobin_g_dl": {
          "mean": 13.4,
          "sd": 1.1
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-0932",
          "description": "myalgia",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-0962",
          "description": "lymphadenopathy",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-0971",
          "description": "chills",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        }
      ],
      "events": [
        "T-cell assay batch B09 processed, results QC'd",
        "DSMB safety review teleconference completed"
      ],
      "notes": "Week 9: Immunogenicity assessments on schedule. 106 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 10,
      "date": "2024-05-06",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 107,
        "active": 103,
        "screen_failures_cumulative": 17,
        "withdrawals_cumulative": 4,
        "by_dose_group": {
          "low_dose": 26,
          "mid_dose": 26,
          "high_dose": 26,
          "placebo": 29
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 63.5,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 16.4,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 105.4,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 156.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 114.0,
            "sd": 11.0
          },
          "seroconversion_pct": 30.1
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 103.9,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 31.1,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 161.3,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 243.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 175.0,
            "sd": 18.0
          },
          "seroconversion_pct": 37.0
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 141.4,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 39.1,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 230.0,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 352.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 246.0,
            "sd": 24.0
          },
          "seroconversion_pct": 56.7
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 17.6,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 2.4,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 21.8,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 34.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 23.0,
            "sd": 2.0
          },
          "seroconversion_pct": 1.3
        }
      },
      "injection_site_reactions": {
        "pain_pct": 58.1,
        "erythema_pct": 18.6,
        "swelling_pct": 15.6,
        "induration_pct": 8.1,
        "mean_pain_duration_hours": 40.9
      },
      "systemic_reactogenicity": {
        "fever_pct": 12.1,
        "fatigue_pct": 25.9,
        "myalgia_pct": 18.5,
        "headache_pct": 15.8,
        "chills_pct": 14.0
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 7.1,
          "sd": 1.7
        },
        "lymphocyte_pct": {
          "mean": 39.6,
          "sd": 5.4
        },
        "neutrophil_pct": {
          "mean": 61.7,
          "sd": 9.4
        },
        "platelets_k": {
          "mean": 245,
          "sd": 36
        },
        "crp_mg_l": {
          "mean": 3.2,
          "sd": 1.9
        },
        "hemoglobin_g_dl": {
          "mean": 14.4,
          "sd": 1.5
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-1045",
          "description": "myalgia",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-1045",
          "description": "injection site pain",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-1025",
          "description": "fatigue",
          "grade": 1,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "high_dose"
        }
      ],
      "events": [
        "Vaccination day 4: 12 subjects received scheduled dose",
        "Cold chain temperature log reviewed: all within -70C +/- 5C",
        "T-cell assay batch B10 processed, results QC'd"
      ],
      "notes": "Week 10: Immunogenicity assessments on schedule. 107 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 11,
      "date": "2024-05-13",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 105,
        "active": 101,
        "screen_failures_cumulative": 19,
        "withdrawals_cumulative": 4,
        "by_dose_group": {
          "low_dose": 25,
          "mid_dose": 26,
          "high_dose": 27,
          "placebo": 27
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 74.5,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 16.8,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 108.0,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 180.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 131.0,
            "sd": 11.0
          },
          "seroconversion_pct": 32.4
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 115.0,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 27.9,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 185.7,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 283.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 192.0,
            "sd": 18.0
          },
          "seroconversion_pct": 48.9
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 162.4,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 38.4,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 250.2,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 392.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 263.0,
            "sd": 24.0
          },
          "seroconversion_pct": 60.6
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 10.1,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 2.9,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 29.8,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 35.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 31.0,
            "sd": 2.0
          },
          "seroconversion_pct": 8.4
        }
      },
      "injection_site_reactions": {
        "pain_pct": 43.4,
        "erythema_pct": 21.1,
        "swelling_pct": 5.5,
        "induration_pct": 7.2,
        "mean_pain_duration_hours": 27.6
      },
      "systemic_reactogenicity": {
        "fever_pct": 22.3,
        "fatigue_pct": 32.0,
        "myalgia_pct": 23.1,
        "headache_pct": 23.9,
        "chills_pct": 8.7
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 8.7,
          "sd": 1.4
        },
        "lymphocyte_pct": {
          "mean": 34.2,
          "sd": 7.6
        },
        "neutrophil_pct": {
          "mean": 63.8,
          "sd": 8.3
        },
        "platelets_k": {
          "mean": 245,
          "sd": 42
        },
        "crp_mg_l": {
          "mean": 3.6,
          "sd": 0.6
        },
        "hemoglobin_g_dl": {
          "mean": 13.1,
          "sd": 1.1
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-1137",
          "description": "injection site pain",
          "grade": 1,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-1163",
          "description": "malaise",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-1182",
          "description": "malaise",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        }
      ],
      "events": [
        "Site 04 monitoring visit, 0 minor findings",
        "DSMB safety review teleconference completed",
        "Vaccination day 6: 22 subjects received scheduled dose"
      ],
      "notes": "Week 11: Immunogenicity assessments on schedule. 105 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 12,
      "date": "2024-05-20",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 103,
        "active": 99,
        "screen_failures_cumulative": 15,
        "withdrawals_cumulative": 4,
        "by_dose_group": {
          "low_dose": 24,
          "mid_dose": 26,
          "high_dose": 26,
          "placebo": 27
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 75.3,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 16.4,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 122.3,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 199.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 130.0,
            "sd": 11.0
          },
          "seroconversion_pct": 33.6
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 130.2,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 30.3,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 211.4,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 317.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 216.0,
            "sd": 18.0
          },
          "seroconversion_pct": 48.7
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 180.8,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 38.6,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 276.6,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 420.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 298.0,
            "sd": 24.0
          },
          "seroconversion_pct": 75.0
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 18.4,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 6.2,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 32.8,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 33.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 23.0,
            "sd": 2.0
          },
          "seroconversion_pct": 4.0
        }
      },
      "injection_site_reactions": {
        "pain_pct": 49.7,
        "erythema_pct": 12.1,
        "swelling_pct": 14.6,
        "induration_pct": 7.5,
        "mean_pain_duration_hours": 35.1
      },
      "systemic_reactogenicity": {
        "fever_pct": 15.1,
        "fatigue_pct": 23.5,
        "myalgia_pct": 31.6,
        "headache_pct": 22.5,
        "chills_pct": 10.3
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 6.1,
          "sd": 1.1
        },
        "lymphocyte_pct": {
          "mean": 29.2,
          "sd": 7.9
        },
        "neutrophil_pct": {
          "mean": 45.1,
          "sd": 6.7
        },
        "platelets_k": {
          "mean": 246,
          "sd": 39
        },
        "crp_mg_l": {
          "mean": 5.5,
          "sd": 0.9
        },
        "hemoglobin_g_dl": {
          "mean": 13.6,
          "sd": 1.5
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-1235",
          "description": "myalgia",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-1270",
          "description": "malaise",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        }
      ],
      "events": [
        "Reactogenicity diary card collection rate: 94%",
        "Vaccination day 2: 19 subjects received scheduled dose"
      ],
      "notes": "Week 12: Immunogenicity assessments on schedule. 103 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 13,
      "date": "2024-05-27",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 105,
        "active": 100,
        "screen_failures_cumulative": 17,
        "withdrawals_cumulative": 5,
        "by_dose_group": {
          "low_dose": 24,
          "mid_dose": 25,
          "high_dose": 29,
          "placebo": 27
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 77.9,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 19.3,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 126.3,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 196.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 131.0,
            "sd": 11.0
          },
          "seroconversion_pct": 27.9
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 123.6,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 27.4,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 197.1,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 306.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 210.0,
            "sd": 18.0
          },
          "seroconversion_pct": 52.0
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 172.1,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 41.1,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 274.0,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 414.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 285.0,
            "sd": 24.0
          },
          "seroconversion_pct": 71.1
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 20.5,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 5.6,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 25.3,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 45.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 22.0,
            "sd": 2.0
          },
          "seroconversion_pct": 9.5
        }
      },
      "injection_site_reactions": {
        "pain_pct": 35.6,
        "erythema_pct": 23.6,
        "swelling_pct": 6.5,
        "induration_pct": 9.7,
        "mean_pain_duration_hours": 16.6
      },
      "systemic_reactogenicity": {
        "fever_pct": 11.5,
        "fatigue_pct": 24.5,
        "myalgia_pct": 24.0,
        "headache_pct": 17.8,
        "chills_pct": 8.6
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 5.8,
          "sd": 1.0
        },
        "lymphocyte_pct": {
          "mean": 34.7,
          "sd": 7.3
        },
        "neutrophil_pct": {
          "mean": 57.5,
          "sd": 6.0
        },
        "platelets_k": {
          "mean": 226,
          "sd": 41
        },
        "crp_mg_l": {
          "mean": 5.1,
          "sd": 2.0
        },
        "hemoglobin_g_dl": {
          "mean": 13.1,
          "sd": 1.2
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-1328",
          "description": "nausea",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-1347",
          "description": "lymphadenopathy",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-1306",
          "description": "malaise",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-1326",
          "description": "fever",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        }
      ],
      "events": [
        "DSMB safety review teleconference completed",
        "Immunology core lab QC report received"
      ],
      "notes": "Week 13: Immunogenicity assessments on schedule. 105 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 14,
      "date": "2024-06-03",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 106,
        "active": 100,
        "screen_failures_cumulative": 17,
        "withdrawals_cumulative": 6,
        "by_dose_group": {
          "low_dose": 24,
          "mid_dose": 27,
          "high_dose": 26,
          "placebo": 29
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 74.0,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 18.3,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 124.6,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 186.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 124.0,
            "sd": 11.0
          },
          "seroconversion_pct": 31.2
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 126.1,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 29.5,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 187.2,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 285.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 204.0,
            "sd": 18.0
          },
          "seroconversion_pct": 53.2
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 166.2,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 39.7,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 261.8,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 403.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 284.0,
            "sd": 24.0
          },
          "seroconversion_pct": 63.0
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 15.5,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 6.7,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 20.9,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 35.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 30.0,
            "sd": 2.0
          },
          "seroconversion_pct": 8.4
        }
      },
      "injection_site_reactions": {
        "pain_pct": 57.0,
        "erythema_pct": 15.5,
        "swelling_pct": 13.6,
        "induration_pct": 10.0,
        "mean_pain_duration_hours": 34.6
      },
      "systemic_reactogenicity": {
        "fever_pct": 20.8,
        "fatigue_pct": 42.4,
        "myalgia_pct": 27.0,
        "headache_pct": 16.6,
        "chills_pct": 7.1
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 5.5,
          "sd": 1.9
        },
        "lymphocyte_pct": {
          "mean": 34.0,
          "sd": 5.5
        },
        "neutrophil_pct": {
          "mean": 50.0,
          "sd": 5.7
        },
        "platelets_k": {
          "mean": 241,
          "sd": 44
        },
        "crp_mg_l": {
          "mean": 3.6,
          "sd": 0.6
        },
        "hemoglobin_g_dl": {
          "mean": 13.9,
          "sd": 1.2
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-1431",
          "description": "injection site pain",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-1450",
          "description": "arthralgia",
          "grade": 1,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-1414",
          "description": "headache",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-1498",
          "description": "chills",
          "grade": 1,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "high_dose"
        }
      ],
      "events": [
        "Serology samples shipped to central immunology lab",
        "Cold chain temperature log reviewed: all within -70C +/- 5C"
      ],
      "notes": "Week 14: Immunogenicity assessments on schedule. 106 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 15,
      "date": "2024-06-10",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 107,
        "active": 103,
        "screen_failures_cumulative": 18,
        "withdrawals_cumulative": 4,
        "by_dose_group": {
          "low_dose": 25,
          "mid_dose": 27,
          "high_dose": 26,
          "placebo": 29
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 76.1,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 21.7,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 120.7,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 177.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 129.0,
            "sd": 11.0
          },
          "seroconversion_pct": 29.8
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 117.8,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 27.5,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 181.5,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 290.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 207.0,
            "sd": 18.0
          },
          "seroconversion_pct": 45.1
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 159.6,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 43.6,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 263.7,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 390.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 278.0,
            "sd": 24.0
          },
          "seroconversion_pct": 62.5
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 10.1,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 5.3,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 29.9,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 41.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 23.0,
            "sd": 2.0
          },
          "seroconversion_pct": 8.2
        }
      },
      "injection_site_reactions": {
        "pain_pct": 48.3,
        "erythema_pct": 23.8,
        "swelling_pct": 15.7,
        "induration_pct": 6.7,
        "mean_pain_duration_hours": 27.0
      },
      "systemic_reactogenicity": {
        "fever_pct": 11.9,
        "fatigue_pct": 29.5,
        "myalgia_pct": 26.1,
        "headache_pct": 15.7,
        "chills_pct": 14.7
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 7.7,
          "sd": 1.5
        },
        "lymphocyte_pct": {
          "mean": 26.1,
          "sd": 7.5
        },
        "neutrophil_pct": {
          "mean": 64.4,
          "sd": 6.6
        },
        "platelets_k": {
          "mean": 218,
          "sd": 43
        },
        "crp_mg_l": {
          "mean": 3.8,
          "sd": 1.9
        },
        "hemoglobin_g_dl": {
          "mean": 13.6,
          "sd": 1.4
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-1587",
          "description": "fatigue",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-1524",
          "description": "fatigue",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        }
      ],
      "events": [
        "Vaccination day 6: 22 subjects received scheduled dose",
        "Immunology core lab QC report received"
      ],
      "notes": "Week 15: Immunogenicity assessments on schedule. 107 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 16,
      "date": "2024-06-17",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 128,
        "active": 121,
        "screen_failures_cumulative": 23,
        "withdrawals_cumulative": 7,
        "by_dose_group": {
          "low_dose": 31,
          "mid_dose": 32,
          "high_dose": 32,
          "placebo": 33
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 76.3,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 18.9,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 117.6,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 177.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 118.0,
            "sd": 11.0
          },
          "seroconversion_pct": 28.1
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 115.9,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 27.1,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 189.8,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 270.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 203.0,
            "sd": 18.0
          },
          "seroconversion_pct": 49.9
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 155.2,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 40.0,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 257.9,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 380.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 267.0,
            "sd": 24.0
          },
          "seroconversion_pct": 64.4
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 12.0,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 1.8,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 27.3,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 35.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 28.0,
            "sd": 2.0
          },
          "seroconversion_pct": 10.2
        }
      },
      "injection_site_reactions": {
        "pain_pct": 50.9,
        "erythema_pct": 25.4,
        "swelling_pct": 12.2,
        "induration_pct": 3.7,
        "mean_pain_duration_hours": 33.0
      },
      "systemic_reactogenicity": {
        "fever_pct": 18.8,
        "fatigue_pct": 41.0,
        "myalgia_pct": 26.6,
        "headache_pct": 27.6,
        "chills_pct": 6.9
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 7.6,
          "sd": 1.1
        },
        "lymphocyte_pct": {
          "mean": 34.4,
          "sd": 6.2
        },
        "neutrophil_pct": {
          "mean": 61.1,
          "sd": 5.2
        },
        "platelets_k": {
          "mean": 229,
          "sd": 41
        },
        "crp_mg_l": {
          "mean": 6.3,
          "sd": 0.6
        },
        "hemoglobin_g_dl": {
          "mean": 14.8,
          "sd": 1.1
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-1658",
          "description": "fever",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-1626",
          "description": "lymphadenopathy",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        }
      ],
      "events": [
        "Vaccine lot VX-825 temperature excursion assessed: within acceptable range",
        "Immunology core lab QC report received"
      ],
      "notes": "Week 16: Immunogenicity assessments on schedule. 128 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 17,
      "date": "2024-06-24",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 126,
        "active": 119,
        "screen_failures_cumulative": 25,
        "withdrawals_cumulative": 7,
        "by_dose_group": {
          "low_dose": 31,
          "mid_dose": 30,
          "high_dose": 33,
          "placebo": 32
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 71.4,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 20.6,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 105.5,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 169.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 122.0,
            "sd": 11.0
          },
          "seroconversion_pct": 32.9
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 108.4,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 29.3,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 186.2,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 270.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 192.0,
            "sd": 18.0
          },
          "seroconversion_pct": 44.0
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 150.2,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 39.5,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 245.1,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 379.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 254.0,
            "sd": 24.0
          },
          "seroconversion_pct": 58.8
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 16.1,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 6.2,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 18.0,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 35.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 29.0,
            "sd": 2.0
          },
          "seroconversion_pct": 6.5
        }
      },
      "injection_site_reactions": {
        "pain_pct": 37.5,
        "erythema_pct": 19.9,
        "swelling_pct": 18.6,
        "induration_pct": 7.5,
        "mean_pain_duration_hours": 33.5
      },
      "systemic_reactogenicity": {
        "fever_pct": 17.4,
        "fatigue_pct": 33.5,
        "myalgia_pct": 27.9,
        "headache_pct": 25.0,
        "chills_pct": 8.7
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 7.0,
          "sd": 1.5
        },
        "lymphocyte_pct": {
          "mean": 30.1,
          "sd": 7.7
        },
        "neutrophil_pct": {
          "mean": 49.5,
          "sd": 7.7
        },
        "platelets_k": {
          "mean": 241,
          "sd": 40
        },
        "crp_mg_l": {
          "mean": 5.1,
          "sd": 1.6
        },
        "hemoglobin_g_dl": {
          "mean": 13.7,
          "sd": 0.9
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-1745",
          "description": "lymphadenopathy",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-1743",
          "description": "fatigue",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-1715",
          "description": "chills",
          "grade": 1,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-1782",
          "description": "malaise",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        }
      ],
      "events": [
        "Vaccine lot VX-857 temperature excursion assessed: within acceptable range",
        "Vaccine lot VX-943 temperature excursion assessed: within acceptable range"
      ],
      "notes": "Week 17: Immunogenicity assessments on schedule. 126 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 18,
      "date": "2024-07-01",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 124,
        "active": 117,
        "screen_failures_cumulative": 31,
        "withdrawals_cumulative": 7,
        "by_dose_group": {
          "low_dose": 29,
          "mid_dose": 31,
          "high_dose": 32,
          "placebo": 32
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 72.1,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 17.8,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 115.7,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 164.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 118.0,
            "sd": 11.0
          },
          "seroconversion_pct": 30.5
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 108.4,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 29.4,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 175.5,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 259.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 192.0,
            "sd": 18.0
          },
          "seroconversion_pct": 44.5
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 149.7,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 41.4,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 240.2,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 363.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 249.0,
            "sd": 24.0
          },
          "seroconversion_pct": 63.8
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 10.4,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 4.1,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 21.8,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 39.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 18.0,
            "sd": 2.0
          },
          "seroconversion_pct": 1.2
        }
      },
      "injection_site_reactions": {
        "pain_pct": 35.6,
        "erythema_pct": 23.4,
        "swelling_pct": 11.5,
        "induration_pct": 7.7,
        "mean_pain_duration_hours": 17.2
      },
      "systemic_reactogenicity": {
        "fever_pct": 16.1,
        "fatigue_pct": 28.4,
        "myalgia_pct": 20.3,
        "headache_pct": 25.5,
        "chills_pct": 5.7
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 8.7,
          "sd": 2.0
        },
        "lymphocyte_pct": {
          "mean": 33.9,
          "sd": 6.1
        },
        "neutrophil_pct": {
          "mean": 55.2,
          "sd": 8.3
        },
        "platelets_k": {
          "mean": 226,
          "sd": 39
        },
        "crp_mg_l": {
          "mean": 2.3,
          "sd": 0.6
        },
        "hemoglobin_g_dl": {
          "mean": 13.8,
          "sd": 1.3
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-1847",
          "description": "arthralgia",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-1879",
          "description": "fatigue",
          "grade": 2,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-1884",
          "description": "chills",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        }
      ],
      "events": [
        "DSMB safety review teleconference completed",
        "Serum sample aliquoting completed for 18 subjects"
      ],
      "notes": "Week 18: Immunogenicity assessments on schedule. 124 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 19,
      "date": "2024-07-08",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 125,
        "active": 118,
        "screen_failures_cumulative": 32,
        "withdrawals_cumulative": 7,
        "by_dose_group": {
          "low_dose": 29,
          "mid_dose": 32,
          "high_dose": 32,
          "placebo": 32
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 61.2,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 17.2,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 110.5,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 168.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 120.0,
            "sd": 11.0
          },
          "seroconversion_pct": 22.4
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 107.3,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 32.1,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 171.3,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 252.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 183.0,
            "sd": 18.0
          },
          "seroconversion_pct": 43.1
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 147.3,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 39.1,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 229.3,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 350.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 244.0,
            "sd": 24.0
          },
          "seroconversion_pct": 55.5
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 13.0,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 0.8,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 23.0,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 39.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 23.0,
            "sd": 2.0
          },
          "seroconversion_pct": 1.7
        }
      },
      "injection_site_reactions": {
        "pain_pct": 51.7,
        "erythema_pct": 26.0,
        "swelling_pct": 15.0,
        "induration_pct": 8.5,
        "mean_pain_duration_hours": 31.5
      },
      "systemic_reactogenicity": {
        "fever_pct": 16.3,
        "fatigue_pct": 42.7,
        "myalgia_pct": 29.4,
        "headache_pct": 23.2,
        "chills_pct": 14.0
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 8.4,
          "sd": 1.8
        },
        "lymphocyte_pct": {
          "mean": 25.7,
          "sd": 5.2
        },
        "neutrophil_pct": {
          "mean": 54.4,
          "sd": 5.6
        },
        "platelets_k": {
          "mean": 220,
          "sd": 39
        },
        "crp_mg_l": {
          "mean": 7.4,
          "sd": 0.8
        },
        "hemoglobin_g_dl": {
          "mean": 13.1,
          "sd": 1.5
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-1934",
          "description": "lymphadenopathy",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-1973",
          "description": "headache",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-1920",
          "description": "malaise",
          "grade": 2,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-1954",
          "description": "fatigue",
          "grade": 1,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-1911",
          "description": "injection site pain",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        }
      ],
      "events": [
        "Serology samples shipped to central immunology lab",
        "Vaccination day 2: 12 subjects received scheduled dose"
      ],
      "notes": "Week 19: Immunogenicity assessments on schedule. 125 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 20,
      "date": "2024-07-15",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 126,
        "active": 117,
        "screen_failures_cumulative": 35,
        "withdrawals_cumulative": 9,
        "by_dose_group": {
          "low_dose": 30,
          "mid_dose": 31,
          "high_dose": 31,
          "placebo": 34
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 64.1,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 18.9,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 96.6,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 161.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 111.0,
            "sd": 11.0
          },
          "seroconversion_pct": 29.5
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 106.8,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 29.9,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 169.4,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 246.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 179.0,
            "sd": 18.0
          },
          "seroconversion_pct": 42.5
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 140.6,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 41.9,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 222.9,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 329.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 242.0,
            "sd": 24.0
          },
          "seroconversion_pct": 53.7
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 15.3,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 3.1,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 19.1,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 39.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 28.0,
            "sd": 2.0
          },
          "seroconversion_pct": 6.7
        }
      },
      "injection_site_reactions": {
        "pain_pct": 55.1,
        "erythema_pct": 23.9,
        "swelling_pct": 11.5,
        "induration_pct": 10.5,
        "mean_pain_duration_hours": 34.3
      },
      "systemic_reactogenicity": {
        "fever_pct": 16.4,
        "fatigue_pct": 21.9,
        "myalgia_pct": 31.5,
        "headache_pct": 23.0,
        "chills_pct": 11.5
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 5.7,
          "sd": 1.7
        },
        "lymphocyte_pct": {
          "mean": 38.6,
          "sd": 6.7
        },
        "neutrophil_pct": {
          "mean": 51.5,
          "sd": 8.0
        },
        "platelets_k": {
          "mean": 225,
          "sd": 44
        },
        "crp_mg_l": {
          "mean": 6.9,
          "sd": 1.0
        },
        "hemoglobin_g_dl": {
          "mean": 14.7,
          "sd": 1.2
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-2068",
          "description": "chills",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-2023",
          "description": "headache",
          "grade": 1,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-2009",
          "description": "malaise",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-2054",
          "description": "nausea",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        }
      ],
      "events": [
        "DSMB safety review teleconference completed",
        "Reactogenicity diary card collection rate: 95%",
        "Site 03 monitoring visit, 3 minor findings"
      ],
      "notes": "Week 20: Immunogenicity assessments on schedule. 126 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 21,
      "date": "2024-07-22",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 128,
        "active": 121,
        "screen_failures_cumulative": 34,
        "withdrawals_cumulative": 7,
        "by_dose_group": {
          "low_dose": 31,
          "mid_dose": 31,
          "high_dose": 33,
          "placebo": 33
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 58.5,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 17.3,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 96.3,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 158.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 102.0,
            "sd": 11.0
          },
          "seroconversion_pct": 27.6
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 99.0,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 28.8,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 154.1,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 235.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 171.0,
            "sd": 18.0
          },
          "seroconversion_pct": 40.5
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 133.7,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 44.0,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 219.7,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 334.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 227.0,
            "sd": 24.0
          },
          "seroconversion_pct": 58.0
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 14.9,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 5.3,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 15.4,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 36.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 13.0,
            "sd": 2.0
          },
          "seroconversion_pct": 6.8
        }
      },
      "injection_site_reactions": {
        "pain_pct": 43.2,
        "erythema_pct": 28.9,
        "swelling_pct": 19.6,
        "induration_pct": 3.6,
        "mean_pain_duration_hours": 21.8
      },
      "systemic_reactogenicity": {
        "fever_pct": 21.8,
        "fatigue_pct": 20.5,
        "myalgia_pct": 23.5,
        "headache_pct": 15.2,
        "chills_pct": 12.5
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 6.2,
          "sd": 1.6
        },
        "lymphocyte_pct": {
          "mean": 27.0,
          "sd": 5.2
        },
        "neutrophil_pct": {
          "mean": 52.2,
          "sd": 8.2
        },
        "platelets_k": {
          "mean": 242,
          "sd": 41
        },
        "crp_mg_l": {
          "mean": 3.1,
          "sd": 1.2
        },
        "hemoglobin_g_dl": {
          "mean": 13.6,
          "sd": 1.2
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-2166",
          "description": "myalgia",
          "grade": 2,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-2141",
          "description": "malaise",
          "grade": 1,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "mid_dose"
        }
      ],
      "events": [
        "Vaccine lot VX-877 temperature excursion assessed: within acceptable range",
        "Reactogenicity diary card collection rate: 96%",
        "Vaccination day 1: 25 subjects received scheduled dose"
      ],
      "notes": "Week 21: Immunogenicity assessments on schedule. 128 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 22,
      "date": "2024-07-29",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 125,
        "active": 116,
        "screen_failures_cumulative": 30,
        "withdrawals_cumulative": 9,
        "by_dose_group": {
          "low_dose": 29,
          "mid_dose": 31,
          "high_dose": 32,
          "placebo": 33
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 59.3,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 16.1,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 96.7,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 146.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 102.0,
            "sd": 11.0
          },
          "seroconversion_pct": 27.5
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 97.2,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 30.3,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 153.1,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 236.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 166.0,
            "sd": 18.0
          },
          "seroconversion_pct": 41.6
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 136.3,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 43.9,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 210.0,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 308.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 224.0,
            "sd": 24.0
          },
          "seroconversion_pct": 51.7
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 7.0,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 5.9,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 11.2,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 20.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 14.0,
            "sd": 2.0
          },
          "seroconversion_pct": 4.3
        }
      },
      "injection_site_reactions": {
        "pain_pct": 36.1,
        "erythema_pct": 29.8,
        "swelling_pct": 19.6,
        "induration_pct": 5.5,
        "mean_pain_duration_hours": 32.5
      },
      "systemic_reactogenicity": {
        "fever_pct": 11.0,
        "fatigue_pct": 28.3,
        "myalgia_pct": 20.3,
        "headache_pct": 23.2,
        "chills_pct": 12.5
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 8.9,
          "sd": 1.4
        },
        "lymphocyte_pct": {
          "mean": 37.5,
          "sd": 5.4
        },
        "neutrophil_pct": {
          "mean": 47.8,
          "sd": 9.5
        },
        "platelets_k": {
          "mean": 253,
          "sd": 40
        },
        "crp_mg_l": {
          "mean": 7.1,
          "sd": 1.3
        },
        "hemoglobin_g_dl": {
          "mean": 13.8,
          "sd": 1.1
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-2255",
          "description": "myalgia",
          "grade": 1,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-2265",
          "description": "fever",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        }
      ],
      "events": [
        "Serology samples shipped to central immunology lab",
        "Immunology core lab QC report received",
        "Immunology core lab QC report received"
      ],
      "notes": "Week 22: Immunogenicity assessments on schedule. 125 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 23,
      "date": "2024-08-05",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 127,
        "active": 119,
        "screen_failures_cumulative": 30,
        "withdrawals_cumulative": 8,
        "by_dose_group": {
          "low_dose": 29,
          "mid_dose": 32,
          "high_dose": 32,
          "placebo": 34
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 62.1,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 18.8,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 99.1,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 143.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 106.0,
            "sd": 11.0
          },
          "seroconversion_pct": 22.2
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 90.7,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 29.3,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 152.4,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 223.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 166.0,
            "sd": 18.0
          },
          "seroconversion_pct": 34.8
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 124.8,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 40.0,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 196.6,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 316.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 215.0,
            "sd": 24.0
          },
          "seroconversion_pct": 49.5
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 15.7,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 1.3,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 26.5,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 27.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 18.0,
            "sd": 2.0
          },
          "seroconversion_pct": 1.5
        }
      },
      "injection_site_reactions": {
        "pain_pct": 48.5,
        "erythema_pct": 28.2,
        "swelling_pct": 15.2,
        "induration_pct": 8.5,
        "mean_pain_duration_hours": 16.6
      },
      "systemic_reactogenicity": {
        "fever_pct": 12.7,
        "fatigue_pct": 37.2,
        "myalgia_pct": 19.9,
        "headache_pct": 26.9,
        "chills_pct": 10.4
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 5.9,
          "sd": 1.3
        },
        "lymphocyte_pct": {
          "mean": 35.8,
          "sd": 6.1
        },
        "neutrophil_pct": {
          "mean": 53.8,
          "sd": 6.6
        },
        "platelets_k": {
          "mean": 252,
          "sd": 38
        },
        "crp_mg_l": {
          "mean": 7.2,
          "sd": 1.3
        },
        "hemoglobin_g_dl": {
          "mean": 13.8,
          "sd": 1.1
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-2361",
          "description": "chills",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-2378",
          "description": "arthralgia",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-2331",
          "description": "lymphadenopathy",
          "grade": 2,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "low_dose"
        }
      ],
      "events": [
        "DSMB safety review teleconference completed",
        "Site 03 monitoring visit, 1 minor findings",
        "Serum sample aliquoting completed for 20 subjects"
      ],
      "notes": "Week 23: Immunogenicity assessments on schedule. 127 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 24,
      "date": "2024-08-12",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 124,
        "active": 116,
        "screen_failures_cumulative": 34,
        "withdrawals_cumulative": 8,
        "by_dose_group": {
          "low_dose": 31,
          "mid_dose": 30,
          "high_dose": 31,
          "placebo": 32
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 57.2,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 19.7,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 86.3,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 131.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 99.0,
            "sd": 11.0
          },
          "seroconversion_pct": 24.5
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 92.9,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 31.8,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 146.1,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 217.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 153.0,
            "sd": 18.0
          },
          "seroconversion_pct": 37.7
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 123.9,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 43.1,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 194.1,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 292.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 214.0,
            "sd": 24.0
          },
          "seroconversion_pct": 44.4
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 11.2,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 1.3,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 15.1,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 34.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 24.0,
            "sd": 2.0
          },
          "seroconversion_pct": 5.4
        }
      },
      "injection_site_reactions": {
        "pain_pct": 45.5,
        "erythema_pct": 14.6,
        "swelling_pct": 17.8,
        "induration_pct": 3.5,
        "mean_pain_duration_hours": 16.0
      },
      "systemic_reactogenicity": {
        "fever_pct": 21.8,
        "fatigue_pct": 28.7,
        "myalgia_pct": 27.9,
        "headache_pct": 24.7,
        "chills_pct": 14.0
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 8.1,
          "sd": 1.6
        },
        "lymphocyte_pct": {
          "mean": 35.2,
          "sd": 7.3
        },
        "neutrophil_pct": {
          "mean": 57.8,
          "sd": 9.9
        },
        "platelets_k": {
          "mean": 227,
          "sd": 40
        },
        "crp_mg_l": {
          "mean": 4.4,
          "sd": 1.5
        },
        "hemoglobin_g_dl": {
          "mean": 14.0,
          "sd": 1.4
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-2478",
          "description": "myalgia",
          "grade": 1,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-2443",
          "description": "fatigue",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-2424",
          "description": "fatigue",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-2476",
          "description": "myalgia",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        }
      ],
      "events": [
        "Site 01 monitoring visit, 0 minor findings",
        "Cold chain temperature log reviewed: all within -70C +/- 5C",
        "Vaccine lot VX-153 temperature excursion assessed: within acceptable range"
      ],
      "notes": "Week 24: Immunogenicity assessments on schedule. 124 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 25,
      "date": "2024-08-19",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 126,
        "active": 115,
        "screen_failures_cumulative": 43,
        "withdrawals_cumulative": 11,
        "by_dose_group": {
          "low_dose": 30,
          "mid_dose": 31,
          "high_dose": 32,
          "placebo": 33
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 58.2,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 17.0,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 92.2,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 139.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 90.0,
            "sd": 11.0
          },
          "seroconversion_pct": 17.8
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 90.9,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 31.4,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 135.4,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 211.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 145.0,
            "sd": 18.0
          },
          "seroconversion_pct": 36.9
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 118.7,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 41.4,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 193.2,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 278.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 201.0,
            "sd": 24.0
          },
          "seroconversion_pct": 46.8
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 14.4,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 3.1,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 16.7,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 32.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 26.0,
            "sd": 2.0
          },
          "seroconversion_pct": 3.8
        }
      },
      "injection_site_reactions": {
        "pain_pct": 40.6,
        "erythema_pct": 23.2,
        "swelling_pct": 7.1,
        "induration_pct": 7.5,
        "mean_pain_duration_hours": 45.0
      },
      "systemic_reactogenicity": {
        "fever_pct": 8.6,
        "fatigue_pct": 21.6,
        "myalgia_pct": 28.2,
        "headache_pct": 24.5,
        "chills_pct": 8.9
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 6.4,
          "sd": 2.0
        },
        "lymphocyte_pct": {
          "mean": 35.6,
          "sd": 8.0
        },
        "neutrophil_pct": {
          "mean": 52.9,
          "sd": 6.1
        },
        "platelets_k": {
          "mean": 250,
          "sd": 38
        },
        "crp_mg_l": {
          "mean": 3.7,
          "sd": 1.5
        },
        "hemoglobin_g_dl": {
          "mean": 14.8,
          "sd": 1.3
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-2506",
          "description": "nausea",
          "grade": 1,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-2547",
          "description": "nausea",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        }
      ],
      "events": [
        "Cold chain temperature log reviewed: all within -70C +/- 5C",
        "Site 05 monitoring visit, 2 minor findings",
        "Immunology core lab QC report received"
      ],
      "notes": "Week 25: Immunogenicity assessments on schedule. 126 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 26,
      "date": "2024-08-26",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 126,
        "active": 116,
        "screen_failures_cumulative": 34,
        "withdrawals_cumulative": 10,
        "by_dose_group": {
          "low_dose": 31,
          "mid_dose": 31,
          "high_dose": 31,
          "placebo": 33
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 54.7,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 18.6,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 86.4,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 126.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 83.0,
            "sd": 11.0
          },
          "seroconversion_pct": 24.3
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 81.4,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 27.3,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 132.5,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 195.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 145.0,
            "sd": 18.0
          },
          "seroconversion_pct": 34.2
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 116.7,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 38.7,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 188.6,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 270.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 196.0,
            "sd": 24.0
          },
          "seroconversion_pct": 42.1
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 10.8,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 5.6,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 16.1,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 25.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 15.0,
            "sd": 2.0
          },
          "seroconversion_pct": 0.8
        }
      },
      "injection_site_reactions": {
        "pain_pct": 37.3,
        "erythema_pct": 26.0,
        "swelling_pct": 15.8,
        "induration_pct": 4.5,
        "mean_pain_duration_hours": 32.5
      },
      "systemic_reactogenicity": {
        "fever_pct": 24.8,
        "fatigue_pct": 26.8,
        "myalgia_pct": 32.6,
        "headache_pct": 28.7,
        "chills_pct": 12.0
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 7.3,
          "sd": 1.6
        },
        "lymphocyte_pct": {
          "mean": 27.3,
          "sd": 7.7
        },
        "neutrophil_pct": {
          "mean": 52.7,
          "sd": 6.4
        },
        "platelets_k": {
          "mean": 252,
          "sd": 43
        },
        "crp_mg_l": {
          "mean": 4.1,
          "sd": 1.9
        },
        "hemoglobin_g_dl": {
          "mean": 14.0,
          "sd": 1.2
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-2612",
          "description": "headache",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-2638",
          "description": "malaise",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        }
      ],
      "events": [
        "Reactogenicity diary card collection rate: 93%",
        "Cold chain temperature log reviewed: all within -70C +/- 5C"
      ],
      "notes": "Week 26: Immunogenicity assessments on schedule. 126 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 27,
      "date": "2024-09-02",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 126,
        "active": 118,
        "screen_failures_cumulative": 42,
        "withdrawals_cumulative": 8,
        "by_dose_group": {
          "low_dose": 30,
          "mid_dose": 31,
          "high_dose": 31,
          "placebo": 34
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 49.5,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 19.4,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 82.5,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 130.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 85.0,
            "sd": 11.0
          },
          "seroconversion_pct": 22.0
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 84.9,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 30.8,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 124.1,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 182.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 137.0,
            "sd": 18.0
          },
          "seroconversion_pct": 32.9
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 106.8,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 40.4,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 168.7,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 271.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 181.0,
            "sd": 24.0
          },
          "seroconversion_pct": 44.2
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 14.2,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 5.7,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 14.3,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 23.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 24.0,
            "sd": 2.0
          },
          "seroconversion_pct": 1.3
        }
      },
      "injection_site_reactions": {
        "pain_pct": 38.5,
        "erythema_pct": 22.4,
        "swelling_pct": 13.6,
        "induration_pct": 3.1,
        "mean_pain_duration_hours": 29.0
      },
      "systemic_reactogenicity": {
        "fever_pct": 12.8,
        "fatigue_pct": 40.2,
        "myalgia_pct": 20.0,
        "headache_pct": 24.6,
        "chills_pct": 11.6
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 7.1,
          "sd": 1.9
        },
        "lymphocyte_pct": {
          "mean": 33.7,
          "sd": 6.8
        },
        "neutrophil_pct": {
          "mean": 51.7,
          "sd": 9.7
        },
        "platelets_k": {
          "mean": 226,
          "sd": 43
        },
        "crp_mg_l": {
          "mean": 1.8,
          "sd": 1.4
        },
        "hemoglobin_g_dl": {
          "mean": 13.9,
          "sd": 1.0
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-2770",
          "description": "fatigue",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-2712",
          "description": "arthralgia",
          "grade": 2,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-2707",
          "description": "myalgia",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-2768",
          "description": "arthralgia",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-2721",
          "description": "lymphadenopathy",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        }
      ],
      "events": [
        "Vaccine lot VX-944 temperature excursion assessed: within acceptable range",
        "Site 01 monitoring visit, 0 minor findings"
      ],
      "notes": "Week 27: Immunogenicity assessments on schedule. 126 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 28,
      "date": "2024-09-09",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 127,
        "active": 116,
        "screen_failures_cumulative": 50,
        "withdrawals_cumulative": 11,
        "by_dose_group": {
          "low_dose": 31,
          "mid_dose": 30,
          "high_dose": 32,
          "placebo": 34
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 43.8,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 21.0,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 77.7,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 108.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 89.0,
            "sd": 11.0
          },
          "seroconversion_pct": 16.0
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 79.8,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 29.3,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 120.1,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 188.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 138.0,
            "sd": 18.0
          },
          "seroconversion_pct": 31.7
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 103.7,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 40.4,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 165.8,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 261.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 173.0,
            "sd": 24.0
          },
          "seroconversion_pct": 46.3
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 12.7,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 4.8,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 20.3,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 28.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 10.0,
            "sd": 2.0
          },
          "seroconversion_pct": 0.8
        }
      },
      "injection_site_reactions": {
        "pain_pct": 42.3,
        "erythema_pct": 27.5,
        "swelling_pct": 6.6,
        "induration_pct": 11.3,
        "mean_pain_duration_hours": 26.1
      },
      "systemic_reactogenicity": {
        "fever_pct": 10.6,
        "fatigue_pct": 36.8,
        "myalgia_pct": 31.4,
        "headache_pct": 20.1,
        "chills_pct": 13.7
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 8.1,
          "sd": 1.3
        },
        "lymphocyte_pct": {
          "mean": 33.4,
          "sd": 7.5
        },
        "neutrophil_pct": {
          "mean": 61.2,
          "sd": 7.8
        },
        "platelets_k": {
          "mean": 230,
          "sd": 41
        },
        "crp_mg_l": {
          "mean": 1.8,
          "sd": 1.6
        },
        "hemoglobin_g_dl": {
          "mean": 14.0,
          "sd": 0.8
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-2852",
          "description": "fever",
          "grade": 2,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-2869",
          "description": "malaise",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-2810",
          "description": "fatigue",
          "grade": 2,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-2891",
          "description": "arthralgia",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-2868",
          "description": "arthralgia",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        }
      ],
      "events": [
        "Cold chain temperature log reviewed: all within -70C +/- 5C",
        "Vaccination day 1: 25 subjects received scheduled dose",
        "Cold chain temperature log reviewed: all within -70C +/- 5C"
      ],
      "notes": "Week 28: Immunogenicity assessments on schedule. 127 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 29,
      "date": "2024-09-16",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 126,
        "active": 112,
        "screen_failures_cumulative": 50,
        "withdrawals_cumulative": 14,
        "by_dose_group": {
          "low_dose": 29,
          "mid_dose": 32,
          "high_dose": 33,
          "placebo": 32
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 48.2,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 21.4,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 68.8,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 101.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 71.0,
            "sd": 11.0
          },
          "seroconversion_pct": 17.3
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 76.7,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 27.6,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 114.2,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 180.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 124.0,
            "sd": 18.0
          },
          "seroconversion_pct": 33.8
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 102.4,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 43.7,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 163.8,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 235.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 178.0,
            "sd": 24.0
          },
          "seroconversion_pct": 36.0
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 7.7,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 5.9,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 11.5,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 28.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 20.0,
            "sd": 2.0
          },
          "seroconversion_pct": 5.3
        }
      },
      "injection_site_reactions": {
        "pain_pct": 58.9,
        "erythema_pct": 23.1,
        "swelling_pct": 16.4,
        "induration_pct": 3.6,
        "mean_pain_duration_hours": 22.2
      },
      "systemic_reactogenicity": {
        "fever_pct": 6.3,
        "fatigue_pct": 39.6,
        "myalgia_pct": 19.0,
        "headache_pct": 20.2,
        "chills_pct": 10.2
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 7.1,
          "sd": 1.3
        },
        "lymphocyte_pct": {
          "mean": 28.9,
          "sd": 6.4
        },
        "neutrophil_pct": {
          "mean": 53.7,
          "sd": 5.1
        },
        "platelets_k": {
          "mean": 227,
          "sd": 42
        },
        "crp_mg_l": {
          "mean": 7.3,
          "sd": 1.5
        },
        "hemoglobin_g_dl": {
          "mean": 14.3,
          "sd": 0.9
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-2903",
          "description": "fever",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-2980",
          "description": "malaise",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-2908",
          "description": "nausea",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        },
        {
          "ae_id": "VI-AE-2931",
          "description": "chills",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "high_dose"
        },
        {
          "ae_id": "VI-AE-2964",
          "description": "headache",
          "grade": 2,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "low_dose"
        }
      ],
      "events": [
        "Serology samples shipped to central immunology lab",
        "Site 02 monitoring visit, 3 minor findings",
        "Vaccine lot VX-588 temperature excursion assessed: within acceptable range"
      ],
      "notes": "Week 29: Immunogenicity assessments on schedule. 126 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    },
    {
      "index": 30,
      "date": "2024-09-23",
      "theme": "vaccine_immunogenicity",
      "enrollment": {
        "total_enrolled": 126,
        "active": 115,
        "screen_failures_cumulative": 40,
        "withdrawals_cumulative": 11,
        "by_dose_group": {
          "low_dose": 29,
          "mid_dose": 31,
          "high_dose": 33,
          "placebo": 33
        }
      },
      "immunogenicity_by_group": {
        "low_dose": {
          "igg_titer_gmu": {
            "mean": 42.4,
            "sd": 6.0
          },
          "igm_titer_gmu": {
            "mean": 16.3,
            "sd": 4.0
          },
          "neutralizing_ab_id50": {
            "mean": 63.7,
            "sd": 10.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 109.0,
            "sd": 15.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 79.0,
            "sd": 11.0
          },
          "seroconversion_pct": 12.6
        },
        "mid_dose": {
          "igg_titer_gmu": {
            "mean": 74.5,
            "sd": 9.6
          },
          "igm_titer_gmu": {
            "mean": 28.3,
            "sd": 6.4
          },
          "neutralizing_ab_id50": {
            "mean": 119.2,
            "sd": 16.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 177.0,
            "sd": 24.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 117.0,
            "sd": 18.0
          },
          "seroconversion_pct": 30.5
        },
        "high_dose": {
          "igg_titer_gmu": {
            "mean": 100.2,
            "sd": 13.2
          },
          "igm_titer_gmu": {
            "mean": 38.5,
            "sd": 8.8
          },
          "neutralizing_ab_id50": {
            "mean": 157.3,
            "sd": 22.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 228.0,
            "sd": 33.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 167.0,
            "sd": 24.0
          },
          "seroconversion_pct": 38.4
        },
        "placebo": {
          "igg_titer_gmu": {
            "mean": 13.5,
            "sd": 1.2
          },
          "igm_titer_gmu": {
            "mean": 5.8,
            "sd": 0.8
          },
          "neutralizing_ab_id50": {
            "mean": 13.9,
            "sd": 2.0
          },
          "cd4_response_sfc_per_10e6": {
            "mean": 23.0,
            "sd": 3.0
          },
          "cd8_response_sfc_per_10e6": {
            "mean": 16.0,
            "sd": 2.0
          },
          "seroconversion_pct": 6.1
        }
      },
      "injection_site_reactions": {
        "pain_pct": 60.2,
        "erythema_pct": 24.2,
        "swelling_pct": 14.1,
        "induration_pct": 6.4,
        "mean_pain_duration_hours": 33.5
      },
      "systemic_reactogenicity": {
        "fever_pct": 16.8,
        "fatigue_pct": 37.2,
        "myalgia_pct": 31.9,
        "headache_pct": 18.9,
        "chills_pct": 12.8
      },
      "safety_labs": {
        "wbc_k": {
          "mean": 5.6,
          "sd": 1.3
        },
        "lymphocyte_pct": {
          "mean": 27.5,
          "sd": 4.9
        },
        "neutrophil_pct": {
          "mean": 63.9,
          "sd": 7.0
        },
        "platelets_k": {
          "mean": 254,
          "sd": 43
        },
        "crp_mg_l": {
          "mean": 3.4,
          "sd": 1.8
        },
        "hemoglobin_g_dl": {
          "mean": 14.7,
          "sd": 1.0
        }
      },
      "adverse_events": [
        {
          "ae_id": "VI-AE-3077",
          "description": "arthralgia",
          "grade": 1,
          "relatedness": "related",
          "resolved": true,
          "dose_group": "mid_dose"
        },
        {
          "ae_id": "VI-AE-3067",
          "description": "injection site pain",
          "grade": 1,
          "relatedness": "possibly related",
          "resolved": true,
          "dose_group": "mid_dose"
        }
      ],
      "events": [
        "DSMB safety review teleconference completed",
        "Serology samples shipped to central immunology lab"
      ],
      "notes": "Week 30: Immunogenicity assessments on schedule. 126 subjects enrolled across dose groups. Reactogenicity profiles consistent with prior weeks."
    }
  ]
}